# Lovaza

NDC: 80725-420
Generic name: OMEGA-3-ACID ETHYL ESTERS
Labeler / Manufacturer: Waylis Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250115

FDA application: NDA021654

## Active ingredients

- OMEGA-3-ACID ETHYL ESTERS: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80725-420"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80725-420
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21cfa4ce-0b05-47ed-b268-339eb1b83b75